The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes
Abstract
The transcriptional effects of the ovarian hormone progesterone are pleiotropic, and binding to DNA of the nuclear progesterone receptor (PR), a ligand-activated transcription factor, results in diverse outcomes in a range of target tissues. To determine whether distinct patterns of genomic interaction of PR contribute to the cell specificity of the PR transcriptome, we have compared the genomic binding sites for PR in breast cancer cells and immortalized normal breast cells. PR binding was correlated with transcriptional outcome in both cell lines, with 60% of progestin-regulated genes associated with one or more PR binding regions. There was a remarkably low overlap between the PR cistromes of the two cell lines, and a similarly low overlap in transcriptional targets. A conserved PR binding element was identified in PR binding regions from both cell lines, but there were distinct patterns of enrichment of known cofactor binding motifs, with FOXA1 sites over-represented in breast cancer cell binding regions and NF1 and AP-1 motifs uniquely enriched in the immortalized normal line. Downstream analyses suggested that differential cofactor availability may generate these distinct PR cistromes, indicating that cofactor levels may modulate PR specificity. Taken together these data suggest that cell-specificity of PR binding is determined by the coordinated effects of key binding cofactors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 also acts as a pioneer transcription factor, binding to specific DNA sequences in the nucleosome to promote transcriptional activation in chromatin.286–288”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [287]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
Lupien, M., Eeckhoute, J., Meyer, C. A., Wang, Q., Zhang, Y., Li, W., Carroll, J. S., Liu, X. S., & Brown, M. (2008) · Cell · doi:10.1016/j.cell.2008.01.018 · Cited by 983
Chromatin accessibility pre-determines glucocorticoid receptor binding patterns
John, S., Sabo, P. J., Thurman, R. E., Sung, M.-H., Biddie, S. C., Johnson, T. A., Hager, G. L., & Stamatoyannopoulos, J. A. (2011) · Nature Genetics · doi:10.1038/ng.759 · Cited by 954
Global gene profiling in human endometrium during the window of implantation
Kao, L. C., Tulac, S., Lobo, S., Imani, B., Yang, J. P., Germeyer, A., Osteen, K., Taylor, R. N., Lessey, B. A., & Giudice, L. C. (2002) · Endocrinology · doi:10.1210/endo.143.6.8885 · Cited by 727
Progestin regulation of cellular proliferation.
CLARKE, C. L., & SUTHERLAND, R. L. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-266 · Cited by 650 · cited 1×
“Progesterone is critical for normal reproductive tissue function [23] and in the uterus supports differentiation, and inhibits proliferation [24].”
BackgroundSelf-citationReddy, T. E., Pauli, F., Sprouse, R. O., Neff, N. F., Newberry, K. M., Garabedian, M. J., & Myers, R. M. (2009) · Genome Research · doi:10.1101/gr.097022.109 · Cited by 543
Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids
Hubler, T. R., & Scammell, J. G. (2004) · Cell Stress & Chaperones · doi:10.1379/csc-32r.1 · Cited by 201
Two Chromatin Remodeling Activities Cooperate during Activation of Hormone Responsive Promoters
Vicent, G. P., Zaurin, R., Nacht, A. S., Li, A., Font-Mateu, J., Le Dily, F., Vermeulen, M., Mann, M., & Beato, M. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000567 · Cited by 55
Research works printed but not linked: 58
- BA Lieberman, 1993, The constitution of a progesterone response element., Mol Endocrinol, 7, 515
- CC Nelson, 1999, Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements., Mol Endocrinol, 13, 2090, 10.1210/mend.13.12.0396 · doi:10.1210/mend.13.12.0396 · Paper page
- SA Onate, 1995, Sequence and characterization of a coactivator for the steroid hormone receptor superfamily., Science, 270, 1354, 10.1126/science.270.5240.1354 · DOI · Paper page
- Z Liu, 2001, Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin., Proc Natl Acad Sci U S A, 98, 12426, 10.1073/pnas.231474798 · DOI
- NJ McKenna, 2002, Combinatorial control of gene expression by nuclear receptors and coregulators., Cell, 108, 465, 10.1016/S0092-8674(02)00641-4 · DOI · Paper page
- KM Scarpin, 2009, Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression., Nucl Recept Signal, 7, e009, 10.1621/nrs.07009 · DOI · Paper page
- GP Vicent, 2006, Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways., Ann N Y Acad Sci, 1089, 59, 10.1196/annals.1386.025 · DOI
- GP Vicent, 2010, Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin., Mol Endocrinol, 24, 2088, 10.1210/me.2010-0027 · DOI
- GP Vicent, 2010, Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements., J Biol Chem, 285, 2622, 10.1074/jbc.M109.060848 · DOI
- JR Friedman, 2006, The Foxa family of transcription factors in development and metabolism., Cell Mol Life Sci, 63, 2317, 10.1007/s00018-006-6095-6 · DOI · Paper page
- GM Bernardo, 2010, FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis., Development, 137, 2045, 10.1242/dev.043299 · DOI · Paper page
- JS Carroll, 2006, Genome-wide analysis of estrogen receptor binding sites., Nat Genet, 38, 1289, 10.1038/ng1901 · DOI · Paper page
- A Hurtado, 2011, FOXA1 is a key determinant of estrogen receptor function and endocrine response., Nat Genet, 43, 27, 10.1038/ng.730 · DOI · Paper page
- Q Wang, 2007, A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth., Mol Cell, 27, 380, 10.1016/j.molcel.2007.05.041 · DOI · Paper page
- L Cicatiello, 2004, Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter., Mol Cell Biol, 24, 7260, 10.1128/MCB.24.16.7260-7274.2004 · DOI · Paper page
- PJ Kushner, 2000, Estrogen receptor pathways to AP-1., J Steroid Biochem Mol Biol, 74, 311, 10.1016/S0960-0760(00)00108-4 · DOI · Paper page
- L Tseng, 2003, Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts., DNA Cell Biol, 22, 633, 10.1089/104454903770238102 · DOI
- W Beguelin, 2010, Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3., Mol Cell Biol, 30, 5456, 10.1128/MCB.00012-10 · DOI
- EJ Faivre, 2008, Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors., Mol Endocrinol, 22, 823, 10.1210/me.2007-0437 · DOI
- JD Graham, 1997, Physiological action of progesterone in target tissues., Endocr Rev, 18, 502
- TA Longacre, 1986, A correlative morphologic study of human breast and endometrium in the menstrual cycle., Am J Surg Pathol, 10, 382, 10.1097/00000478-198606000-00003 · DOI · Paper page
- CI Ace, 2004, Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase., Reprod Biol Endocrinol, 2, 54, 10.1186/1477-7827-2-54 · DOI
- JM Borthwick, 2003, Determination of the transcript profile of human endometrium., Mol Hum Reprod, 9, 19, 10.1093/molehr/gag004 · DOI · Paper page
- JD Graham, 2005, Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells., Mol Endocrinol, 19, 2713, 10.1210/me.2005-0126 · DOI
- JK Richer, 2002, Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells., J Biol Chem, 277, 5209, 10.1074/jbc.M110090200 · DOI · Paper page
- V Beral, 2003, Breast cancer and hormone-replacement therapy in the Million Women Study., Lancet, 362, 419, 10.1016/S0140-6736(03)14596-5 · DOI · Paper page
- V Beral, 2011, Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy., J Natl Cancer Inst, 103, 296, 10.1093/jnci/djq527 · DOI · Paper page
- JE Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial., JAMA, 288, 321, 10.1001/jama.288.3.321 · DOI · Paper page
- RT Chlebowski, 2010, Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women., JAMA, 304, 1684, 10.1001/jama.2010.1500 · DOI · Paper page
- JD Graham, 2009, DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast., Endocrinology, 150, 3318, 10.1210/en.2008-1630 · DOI
- B Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome., Genome Biol, 10, R25, 10.1186/gb-2009-10-3-r25 · DOI · Paper page
- A Mortazavi, 2008, Mapping and quantifying mammalian transcriptomes by RNA-Seq., Nat Methods, 5, 621, 10.1038/nmeth.1226 · DOI · Paper page
- AV Roschke, 2003, Karyotypic complexity of the NCI-60 drug-screening panel., Cancer Res, 63, 8634
- Q Tang, 2011, A comprehensive view of nuclear receptor cancer cistromes., Cancer Res, 71, 6940, 10.1158/0008-5472.CAN-11-2091 · DOI
- D Wang, 2011, Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA., Nature, 474, 390, 10.1038/nature10006 · DOI · Paper page
- R Joseph, 2010, Integrative model of genomic factors for determining binding site selection by estrogen receptor-alpha., Mol Syst Biol, 6, 456, 10.1038/msb.2010.109 · DOI
- R Bravieri, 1997, Different DNA contact schemes are used by two winged helix proteins to recognize a DNA binding sequence., Nucleic Acids Res, 25, 2888, 10.1093/nar/25.14.2888 · DOI
- LA Cirillo, 2007, Specific interactions of the wing domains of FOXA1 transcription factor with DNA., J Mol Biol, 366, 720, 10.1016/j.jmb.2006.11.087 · DOI
- S Pierrou, 1994, Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending., EMBO J, 13, 5002, 10.1002/j.1460-2075.1994.tb06827.x · DOI · Paper page
- WJ Welboren, 2009, ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands., EMBO J, 28, 1418, 10.1038/emboj.2009.88 · DOI · Paper page
- KL Macquarrie, 2011, Genome-wide transcription factor binding: beyond direct target regulation., Trends Genetics, 27, 141, 10.1016/j.tig.2011.01.001 · DOI · Paper page
- SA Krum, 2008, Unique ERalpha cistromes control cell type-specific gene regulation., Molecular Endocrinology, 22, 2393, 10.1210/me.2008-0100 · DOI
- AY So, 2007, Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor., PLoS Genet, 3, e94, 10.1371/journal.pgen.0030094 · DOI · Paper page
- EC Bolton, 2007, Cell- and gene-specific regulation of primary target genes by the androgen receptor., Genes Dev, 21, 2005, 10.1101/gad.1564207 · DOI · Paper page
- P Yin, 2012, Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells., PLoS One, 7, e29021, 10.1371/journal.pone.0029021 · DOI
- GV Rayasam, 2005, Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro., Mol Cell Biol, 25, 2406, 10.1128/MCB.25.6.2406-2418.2005 · DOI
- S Belikov, 2009, FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter., Mol Cell Biol, 29, 5413, 10.1128/MCB.00368-09 · DOI
- I Garcia-Bassets, 2007, Histone methylation-dpendent mechanisms impose ligand dependency for gene activation by nuclear receptors., Cell, 128, 505, 10.1016/j.cell.2006.12.038 · DOI · Paper page
- E Metzger, 2005, LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription., Nature, 437, 436, 10.1038/nature04020 · DOI · Paper page
- J Murtagh, 2003, The Nuclear Factor I (NFI) gene family in mammary gland development and function., J Mammary Gland Biol Neoplasia, 8, 241, 10.1023/A:1025909109843 · DOI
- CH Streuli, 1995, Stat5 as a target for regulation by extracellular matrix., J Biol Chem, 270, 21639, 10.1074/jbc.270.37.21639 · DOI
- CL Clarke, 1987, Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques., Endocrinology, 121, 1123, 10.1210/endo-121-3-1123 · DOI
- H Ji, 2008, An integrated software system for analyzing ChIP-chip and ChIP-seq data., Nat Biotechnol, 26, 1293, 10.1038/nbt.1505 · DOI · Paper page
- S Heinz, 2010, Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities., Mol Cell, 38, 576, 10.1016/j.molcel.2010.05.004 · DOI · Paper page
- TL Bailey, 2006, MEME: discovering and analyzing DNA and protein sequence motifs., Nucleic Acids Res, 34, W369, 10.1093/nar/gkl198 · DOI · Paper page
- TL Bailey, 2010, The value of position-specific priors in motif discovery using MEME., BMC Bioinformatics, 11, 179, 10.1186/1471-2105-11-179 · DOI
- M Reich, 2006, GenePattern 2.0., Nat Genet, 38, 500, 10.1038/ng0506-500 · DOI · Paper page
- JD Graham, 1995, Characterization of progesterone receptor A and B expression in human breast cancer., Cancer Res, 55, 5063
Cited by
Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
Gellersen, B., & Brosens, J. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1045 · Cited by 1,139
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Forkhead box proteins: tuning forks for transcriptional harmony.
Lam, E. W.-F., Brosens, J. J., Gomes, A. R., & Koo, C.-Y. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3539 · Cited by 684
Progesterone receptor modulates ERα action in breast cancer
Mohammed, H., Russell, I. A., Stark, R., Rueda, O. M., Hickey, T. E., Tarulli, G. A., Serandour, A. A., Birrell, S. N., Bruna, A., Saadi, A., et al. (2015) · Nature · doi:10.1038/nature14583 · Cited by 659
Pioneer transcription factors in cell reprogramming
Iwafuchi-Doi, M., & Zaret, K. S. (2014) · Genes & Development · doi:10.1101/gad.253443.114 · Cited by 597
Metadata
- Authors
- Clarke, C. L., & Graham, J. D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-04-24
- Volume
- 7
- Issue
- 4
- Pages
- e35859
- ISSN
- 1932-6203
- Cited by
- 74
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes. https://app.cochat.ai/papers/10.1371/journal.pone.0035859
- The paper
- Clarke, C. L., & Graham, J. D. (2012). Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes. PLoS ONE. https://doi.org/10.1371/journal.pone.0035859
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.